ENDOVIA HEALTH SCIENCES INC
EDVANYSE AMERICAN🏆 #5259 by market capEarnings Nov 17US Equity
$0.17▼ $0.00 (−0.59%)
Market closed · at closeTrack EDVA
Get earnings, price moves & breaking news on Telegram
24h▼ 0.6%
7d▲ 12.6%
14d▲ 19.5%
30d▼ 3.1%
ytd▼ 93.9%
1y▼ 97.7%
🏦Market Cap
$1M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
—
Insufficient data
Trading Snapshot
- Day Range
- $0.17 – $0.17
- 52-Week Range
- $0.13 – $8.60
- Volume (shares)
- 1,552
- Avg Volume (shares)
- —
- Shares Outstanding
- 6.4M
- Next Earnings
- 2026-11-17
Fundamentals Snapshot
- Annual Revenue
- —
- Last Q Revenue
- —
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- —
- Dividend Yield
- —
ENDOVIA HEALTH SCIENCES INC
EDVAFinancial Trends
Financial history unavailable.
StockOtter · stockotter.spaceAbout ENDOVIA HEALTH SCIENCES INC
Endovia Health Sciences is a diversified cannabinoid-based health sciences platform. The company's strategy focuses on three main areas: commercializing differentiated cannabinoid-based pharmaceutical products internationally, advancing cannabinoid-based human and veterinary therapeutics through U.S. regulatory pathways, and developing consumer wellness and beverage products. This marks a strategic transformation from its prior operations as a beverage company.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Overall Score
Insufficient data
—/100
Analyst Ratings
ⓘConsensus
Buy
7 analysts
Strong Buy2
Buy4
Hold1
Sell0
Strong Sell0
Ratings as of Jul 2025
Latest News & Updates
News unavailable.